Attenuated p53 activation in tumour-associated stromal cells accompanies decreased sensitivity to etoposide and vincristine

Por Dudley, A C, Shih, S-C, Cliffe, A R, Hida, K, Klagsbrun, M
Publicado em 2008

A mutated soluble neuropilin-2 B domain antagonizes VEGF bioactivity and inhibits tumor progression

Por Geretti, E, van Meeteren, L. A., Shimizu, A, Dudley, A. C., Claesson-Welsh, L, Klagsbrun, M
Publicado em 2010